69189-0677 : Nifedipine Extended Release 30 mg Oral Tablet, Extended Release


NDC69189-0677
Labeler: Avera Mckennan Hospital
Product Type: Human Prescription Drug
Drug Name:  Nifedipine Extended Release
Dosage Form: Oral Tablet, Extended Release
Application #: ANDA077899
Rev. Date: 


Appearance:


Markings: A;153
Shapes:  Round
Colors:  Yellow
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

A 153: (49884-677) Nifedipine Extended Release 30 mg Oral Tablet, Extended Release by Avera Mckennan Hospital
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 69189-0677-1: 1 TABLET, EXTENDED RELEASE IN 1 DOSE PACK (69189‑0677‑1)

Active Ingredients:

  • Nifedipine

Dosage Strength:

  • 30 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Hypromelloses
  • Lactose Monohydrate
  • Magnesium Stearate
  • Polydextrose
  • Polyethylene Glycol 8000
  • Triacetin
  • Ferric Oxide Yellow
  • Titanium Dioxide

Pharmaceutical Classes:

  • Calcium Channel Antagonists [MoA]
  • Dihydropyridine Calcium Channel Blocker [EPC]
  • Dihydropyridines [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 0904-6544 Nifedipine Extended Release 30 mg Oral Tablet, Extended Release by Major Pharmaceuticals
  • 0904-6545 Nifedipine Extended Release 60 mg Oral Tablet, Extended Release by Major Pharmaceuticals
  • 10370-390 Nifedipine 30 mg Oral Tablet, Extended Release by Par Pharmaceutical, Inc.
  • 10370-391 Nifedipine 60 mg Oral Tablet, Extended Release by Par Pharmaceutical, Inc.
  • 10370-392 Nifedipine 90 mg Oral Tablet, Extended Release by Par Pharmaceutical, Inc.
  • 53808-0898 Nifedipine 30 mg Oral Tablet, Extended Release by State of Florida Doh Central Pharmacy
  • 68084-979 Nifedipine 30 mg Oral Tablet, Extended Release by American Health Packaging
  • 68084-985 Nifedipine 60 mg Oral Tablet, Extended Release by American Health Packaging
  • 68084-993 Nifedipine 90 mg Oral Tablet, Extended Release by American Health Packaging

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69189-0677 QR Code

< Prev: 69189-0676Next: 69189-0678 >

Related Discussions:

nifedipine and dreams
I am taking 60mg of nifedipine and I am having unpleasant dreams every night. Is there an alternative which does not hav... 5 replies
Nifedipine and water retention
I have been taking Nifedipine for a month. I have increased water and swelling in feet, and a lot of pulled muscles. I t... 3 replies
Nifedipine Er 60 mg TER manufacturers
Is Nifedipine ER 60mg TER, a light pinkish tablet with KU261 on one side, and a small hole in the middle of the other si... 3 replies
Nifedipine 30mg er
a nifedipine pill , lavender in color with m030 imprinted on one side. Is this the same pill as M475 pink pill which has... 3 replies
Nifedipine bloop pressure pills
My Nifedipine blood pressure pills got wet. Are they still good to use? ## If it was just water, they wouldn't becom... 2 replies
Nifedipine ER 30mg to 60mg
I have been taking Nifedipibe ER 30mg since March 2016. My doctor increased my dosage up to 60mg Nifedipine starting 10/... 2 replies
Nifedipine for Raynauds
I'm 41, I have suffered in winter for many years from bad circulation, or so I thought! Until I visited the doctor, ... 2 replies
nifedipine AND Atenolol
I was diagnose with high blood pressure (BP) about ten years ago (at 40 years) and my doctor prescribe Atenolo 50 mg whi... 2 replies
Nifedipine ER - double dosed 90 mg
My mom takes a lot of pills and a typo from me caused her to take two 90 mg ER Nifedipine tablets. I am TERRIFIED that I... 1 reply
nifedipine and ascard during pregnancy
I am pregnant (33 weeks) and I don't know if it's ok to use both nifelat 20mg and ascard 75mg to control my bloo... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 August 2018.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA